Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 5/20/2022 10:20:54 PM - Followers: 1486 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Compilations
Biotech Buyouts/Premiums
Biotech-Newbie Misconceptions (see Reply chain)
Biotech Abbreviations and Acronyms
'Way Back' Archive (Greatest Hits 2003-2009)

PostSubject
#242549  Sticky Note Truist analyst Asthika Goonewardene said a previous expert jbog 05/19/22 01:20:14 PM
#242542  Sticky Note ENTA’s valuation: DewDiligence 05/18/22 06:36:27 PM
#242534  Sticky Note NIH wants_to_study longer treatment_course for Paxlovid: DewDiligence 05/18/22 12:47:46 PM
#242467  Sticky Note The macroeconomic environment is unlike anything investors have DewDiligence 05/11/22 04:38:45 PM
#242374  Sticky Note Big Pharma Has Enough Cash to Buy All jbog 05/07/22 11:20:45 AM
#241050  Sticky Note My 2022 picks for the Silicon Investor Charity DewDiligence 01/03/22 11:51:52 AM
#242566   insider buys the last three days. 57_2001 05/20/22 10:20:54 PM
#242565   [OT]—Is it accepted dogma that T causes ovarian DewDiligence 05/20/22 09:16:54 PM
#242564   Is it accepted dogma that T causes ovarian dewophile 05/20/22 07:17:29 PM
#242563   [OT]—This is the "root" post from our prior DewDiligence 05/20/22 06:14:38 PM
#242562   Suppressing the reproductive axis with GnRH agonists was dewophile 05/20/22 05:04:18 PM
#242561   The article says they also may test the DewDiligence 05/20/22 04:38:36 PM
#242560   I can't read the article it seems to dewophile 05/20/22 04:33:51 PM
#242559   FHTX reversed yesterday's AH sell-off and closed plus DewDiligence 05/20/22 04:15:05 PM
#242558   SNY/REGN—FDA approves Dupixent for eosinophilic esophagitis: DewDiligence 05/20/22 03:58:52 PM
#242557   ZYME rejects buyout offer @$10.50/sh cash—a 78% premium DewDiligence 05/20/22 02:26:36 PM
#242556   Boston Globe feature on (private) Olivia Therapeutics: DewDiligence 05/20/22 01:37:45 PM
#242555   ATHX—(-62%)—Phase-2/3 ischemic-stroke trial_misses_primary_ endpoint: DewDiligence 05/20/22 11:22:27 AM
#242554   Yes, and thanks for being patient with my jcrty 05/19/22 08:27:24 PM
#242553   I wouldn't read much into the lease information DewDiligence 05/19/22 04:36:23 PM
#242552   FHTX -29%/AH on partial clinical hold: DewDiligence 05/19/22 04:31:06 PM
#242551   ATRA -15%/AH on Bayer's dropping CAR-T collaboration: DewDiligence 05/19/22 04:26:57 PM
#242550   Truist analyst Asthika Goonewardene said a previous expert vinmantoo 05/19/22 01:36:31 PM
#242549   Truist analyst Asthika Goonewardene said a previous expert jbog 05/19/22 01:20:14 PM
#242548   In day 4 of Cabo patent trial, judge vinmantoo 05/19/22 01:13:10 PM
#242547   In day 4 of Cabo patent trial, judge IanFromSI 05/19/22 01:05:34 PM
#242546   Patent Trial started this week. jbog 05/19/22 01:03:50 PM
#242545   EXEL getting hammered today on no news. vinmantoo 05/19/22 12:14:24 PM
#242544   ENTA Lease (SEC filing) jcrty 05/18/22 09:51:01 PM
#242542   ENTA’s valuation: DewDiligence 05/18/22 06:36:27 PM
#242541   The UK Panoramic antiviral study described here dies mouton29 05/18/22 04:43:29 PM
#242540   For US trial sites, I concur. The issue DewDiligence 05/18/22 04:23:19 PM
#242539   Not directly related to the 5 v longer mouton29 05/18/22 04:20:19 PM
#242538   maybe. prob. but hard to say given how usma67korea 05/18/22 04:17:50 PM
#242537   ENTA’s phase-2b trial in RSV misses primary endpoint: DewDiligence 05/18/22 04:09:15 PM
#242536   Good question. My guess is no—i.e. that ENTA DewDiligence 05/18/22 01:02:41 PM
#242535   NIH wants_to_study longer treatment_course for Paxlovid: vinmantoo 05/18/22 12:53:21 PM
#242534   NIH wants_to_study longer treatment_course for Paxlovid: DewDiligence 05/18/22 12:47:46 PM
#242533   FDA rejects fluvoxamine* for COVID treatment based on DewDiligence 05/18/22 12:14:50 PM
#242532   IMTX - Immatics Announces First Patient Treated with FACT-MASTER 05/18/22 12:03:15 PM
#242531   AMTI prunes pipeline—reduces workforce 40%: DewDiligence 05/18/22 12:00:18 PM
#242530   DTIL publishes mRNA approach to treating HBV: DewDiligence 05/18/22 11:47:36 AM
#242529   rucosopasem is still in early testing. 57_2001 05/18/22 09:12:16 AM
#242528   AVRO .78 - AVROBIO Reports Positive Data From RNsidersbuying 05/17/22 08:54:09 AM
#242527   definitely, and it sounds like a healthcare provider dewophile 05/16/22 05:57:47 PM
#242526   FDA approves LH’s at-home test for COVID/flu/RSV: DewDiligence 05/16/22 05:52:36 PM
#242525   https://www.reuters.com/breakingviews/super-chemo-will-be-big-pharmas-next-tussl Preciouslife1 05/16/22 04:29:07 PM
#242524   Petition for writ of Certiorari in S.Ct. that north40000 05/16/22 03:02:28 PM
#242523   NNVC Worse. The odds they get it as far WorstLuck 05/16/22 02:32:05 PM
#242522   CMRX -61% on sale of smallpox antidote, Tembaxa DewDiligence 05/16/22 02:28:13 PM
#242521   ZNTL +15% on new CEO—and $230M* capital raise DewDiligence 05/16/22 02:19:22 PM
#242520   Yea I thought of that but at this vinmantoo 05/16/22 02:17:31 PM
#242518   NNVC is one of those companies that hops DewDiligence 05/16/22 01:18:48 PM
#242517   Yea I thought of that but at this usma67korea 05/16/22 12:44:37 PM
#242516   I don’t have a fully convincing answer, but DewDiligence 05/16/22 12:41:25 PM
#242515   Anyone has an idea why ENTA has been usma67korea 05/16/22 12:11:11 PM
PostSubject
Consent Preferences